Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

  • Category M prices to increase by £15m per month from August 2019, announces PSNC

    Category M reimbursement prices are to increase by £15m per month from August 2019, the Pharmaceutical Services Negotiating Committee (PSNC) has announced following discussions with the Department of Health and Social Care (DHSC).

    The price increase will help to ensure that the overall amount of margin delivered during the 2019/20 financial year is the agreed annual sum of £800m and should help to ease immediate contractor cashflow issues, the PSNC explained.

    The Single Activity Fee will also rise by 1p to £1.27 per item.

    “The past few months have been incredibly difficult for many community pharmacy contractors, and this has in part been caused by the need to keep Category M reimbursement prices low following excess margins earned in previous financial years,” said Simon Dukes, chief executive of the PSNC.

    “These August price increases are being made to try to correct margin delivery for this financial year and this should bring some relief for contractors.”

    Despite the increases, Dukes said the PSNC was concerned about the impact of cashflow difficulties on pharmacies and was pressing the DHSC to make improvements to the funding and margin distribution systems to try to avoid future problems.

    In April 2019, Category M prices increased by £10m, but the April 2019 reimbursement levels were lower than anticipated, which meant that contractors did not see the positive cashflow impact that they expected, the PSNC said.

     

     

  • Boots and PDA Union sign their first voluntary recognition agreement

    The Pharmacists’ Defence Association (PDA) Union has signed its first voluntary recognition agreement with Boots.

    The formal agreement means that the PDA Union, which now represents store-based Boots pharmacists and pre-registration pharmacists, will negotiate the annual pay for these roles within Boots, starting with the forthcoming annual pay review for the financial year 2019/2020.

    A joint negotiating board made up of a subset of PDA Union representatives will exist negotiations over pay, hours and holidays.

    The agreement includes a list of policy items, including bonus payments and human resource policies, which Boots will inform the PDA Union about if there are any changes.

     

  • pause slideshow

Rekha Shah leads on pharmacy NHS vaccination services for London local pharmaceutical committees

Pharmacists told flu vaccine deliveries will be delayed

Flu vaccine suppliers have told pharmacies that some deliveries of the standard quadrivalent flu vaccine will be delayed until November 2019.

Flu vaccination

Fewer than half of GPs will be able to receive patient flu data from pharmacy this autumn

Four in ten GP practices are expected to be able to receive updates on patients who have their flu vaccination at pharmacies this autumn, NHS Digital has said.

Vaughan Gething, the Welsh minister for health and social services

No new cases of HIV among people in Wales taking PrEP

None of the more than 1,000 people in Wales who have received pre-exposure prophylaxis since it became routinely available have developed HIV while receiving the drugs.

Keith Ridge, chief pharmaceutical officer for England

PCN pharmacists to have role in diagnostics by 2021/2022, says Keith Ridge

Pharmacists will “undoubtedly contribute” to cardiovascular disease prevention and diagnosis as part of primary care networks by 2021/2022, England’s chief pharmaceutical officer, Keith Ridge, has said.

Ambulance

Drug-related deaths in Scotland hit record level

The number of drug-related deaths in Scotland rose to 1,187 in 2018: a figure 27% higher than the previous year, according to data from National Records of Scotland.

Waiting room GP

HEE told it must train 500 clinical pharmacists in 2019/2020

Health Education England has been tasked with training 500 clinical pharmacists for roles in general practice by the end of 2019/2020, the Department of Health and Social Care has said in its annual mandate.

Adalimumab, Humira

Majority of patients not asked for consent before being switched to a biosimilar, survey finds

Less than half of patients (47%) were asked for their consent before being switched to an adalimumab biosimilar, according to the preliminary results of a patient survey carried out by the National Ankylosing Spondylitis Society.

All News

Hospital pharmacy

Most patients with hospital discharge delays blame medicines wait

Nearly three in four patients who were delayed on discharge from hospital said it was because they had to wait for medicines, a Care Quality Commission survey has found.

Martin Sawer, director of the Healthcare Distribution Agency

No-deal Brexit could put UK at greater risk from falsifed medicines, HDA director tells MPs

Leaving the EU without a deal would likely result in the UK being “unplugged” from the Falsified Medicines Directive, Martin Sawer, executive director of the Healthcare Distribution Association, has told a select committee of MPs.

Person using a smartphone

LloydsPharmacy’s parent company buys repeat prescription app

LloydsPharmacy’s parent company, McKesson UK, has bought the online repeat prescription app ‘Echo’ — one of several pharmacy apps now on the NHS Digital app library.

An empty pharmacy counter suggesting difficulties in staff recruitment

Pharmacists excluded from shortage occupation list despite recruitment concerns

A government advisory committee has excluded pharmacists from the shortage occupation list, despite reported difficulties in recruitment.

A woman in a consultation with a psychiatrist

National guidance for antidepressant withdrawal too fast for some patients, says RCPsych

The Royal College of Psychiatrists wants the national clinical guideline governing withdrawal from antidepressants changed because it says the timescale is too quick for some patients.

IV infusion

Medicine safety expert warns against 'unlawful' guidance to discard IV infusion sets

Following national guidance to discard an intravenous infusion set without flushing it is “unlawful”, the former head of safe medication practice at the National Patient Safety Agency has warned.

NHS Pharmacy shop sign

NUMSAS referrals to community pharmacy more than double in a year

The number of referrals to community pharmacy through the NHS Urgent Medicine Supply Advanced Service (NUMSAS) has more than doubled in the past year, according to data from NHS England.

All United Kingdom

Kidney ultrasound

SGLT2 inhibitor lowers risk of kidney failure in type 2 diabetesSubscription

Patients with type 2 diabetes mellitus and chronic kidney disease have a lower risk of kidney failure and cardiovascular events if they are treated with canagliflozin, research has confirmed.

Older person using smartphone

App helps patients cut opioid use after knee replacementSubscription

Patients who underwent knee replacement who used an app to monitor their analgesic use had better pain control and took fewer opioids post surgery, study results show.

Xanax

Concerns raised over non-medical alprazolam useSubscription

The benzodiazepine alprazolam is being obtained for non-medical use in the UK, particularly among young people, a survey has found.

Glucose test for diabetes

Immunotherapy delays type 1 diabetes mellitus in high-risk individualsSubscription

Certain individuals at high risk of developing type 1 diabetes mellitis can delay progression to clinical disease by two years or more with a two-week course of teplizumab, according to a phase II study Source: Shutterstock.com

Vitamin D fish oil supplement

Vitamin D not protective against cardiovascular eventsSubscription

Vitamin D supplementation is not associated with a reduced risk of major cardiovascular events, a meta-analysis suggests.

Methadone

Alzheimer’s drug reduces illicit opioid use in methadone recipientsSubscription

People who take methadone use fewer illicit opioids when galantamine is added to their therapy, research shows.

Osteoarthritis of the hand

Prednisolone reduces hand osteoarthritis pain Subscription

Patients with hand osteoarthritis experienced improvements in pain and function with low-dose prednisolone treatment, according to a study presented at the European Congress of Rheumatology.

Woman using a nasal spray

Esketamine nasal spray effective for rapid improvement of depressive symptomsSubscription

The ketamine-related nasal spray esketamine is effective at relieving the symptoms of treatment-resistant depression, a phase III study has shown.

All Science